DarioHealth
DRIO
47 hedge funds and large institutions have $38.9M invested in DarioHealth in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 5 closing their positions.
146% more call options, than puts
Call options by funds: $870K | Put options by funds: $353K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
4% more funds holding
Funds holding: 45 → 47 (+2)
1% more capital invested
Capital invested by funds: $38.4M → $38.9M (+$541K)
0.19% more ownership
Funds ownership: 1.81% → 2% (+0.19%)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.22M |
| 2 |
AWAM
Appian Way Asset Management
New York
|
+$565K |
| 3 |
Renaissance Technologies
New York
|
+$80.1K |
| 4 |
CCIA
Cherry Creek Investment Advisors
Englewood,
Colorado
|
+$46.5K |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$45.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$2.19M |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$856K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$409K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$250K |
| 5 |
Millennium Management
New York
|
-$147K |
DRIO Hedge Fund Activity: Q4 2022 in Review
47 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2022, worth a combined $38.9M — up 1.4% from $38.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DRIO positions and 5 closed out — a net gain of 2 holders — while 10 added to existing stakes and 14 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $1.22M. The largest seller was Clal Insurance, cutting an estimated $2.19M.
- 47 institutional investors held DarioHealth (DRIO) as of Q4 2022, up from 45 in Q3 2022.
- Funds reported $38.9M of DarioHealth stock for Q4 2022, up 1.4% quarter-over-quarter.
- 7 funds opened new DarioHealth positions in Q4 2022 and 5 closed out, a net change of +2 holders.
- The largest DarioHealth buyer in Q4 2022 was Nantahala Capital Management, an estimated $1.22M added.
- The largest DarioHealth seller in Q4 2022 was Clal Insurance, an estimated $2.19M sold.
Based on aggregated 13F filings for Q4 2022.